Advances in Hematological Malignancies
Recent centuries have witnessed remarkable strides in the domain of hematological malignancies. Novel treatment modalities such as targeted therapy, immunotherapies, and gene editing are revolutionizing the survival rates for patients with blood cancers. Ongoing investigations continue to explore these innovative approaches, offering promise for mo